News

Most dispensary grand openings come with a discount or a free tote bag. Lume Cannabis Co. went bigger-they’re giving away a trip to Mexico. Now open in New Buffalo, Lume’s latest location will officially celebrate its Grand Opening on May 2 with a standout promotion in partnership with Smoorhouse: a two-day giveaway dubbed “From a Lume to a Tulum Weekend Getaway.” One customer wins a trip for two to Tulum, Mexico, flights and accommodation included at a luxury Tulum property. The giveaway runs from 9 a.m. on Saturday, May 2, through 5 p.m. on Sunday, May 3, with the winner announced live on . . .

The Acting Attorney General is getting the ball rolling on the rescheduling of cannabis from Schedule 1 to Schedule 3, earning praise from the cannabis industry. The post Department of Justice makes good on Trump’s rescheduling order appeared first on Leafly.

Gummy production shouldn’t feel like a constant battle with inconsistency, inefficiency, and risk. Yet for many manufacturers, that is exactly what it becomes: long cook times, batch variability, operator error, and the ever-present possibility of lost product. Melt-to-Make was created to change this reality entirely. Designed specifically for modern gummy manufacturers, Melt-to-Make removes common production obstacles by replacing complex, time-consuming cooking processes with a streamlined, repeatable system. The result? Faster production, more consistent output, and a workflow your team . . .

White House officials are giving feedback on pending legislation to create a regulatory framework for hemp amid a swirl of proposals from lawmakers on the issue-including a new amendment that seeks to expedite enforcement of the pending recriminalization of hemp-derived THC products that is currently scheduled for November. On Tuesday, Vince Haley, director of the White House Domestic Policy Council and James Braid, assistant to the president for legislative affairs, sent hemp policy suggestions to Rep. Andy Barr (R-KY), who has been helping to lead efforts to enact regulations for the plant . . .

The Virginia General Assembly on Thursday rejected the changes proposed last week by Gov. Abigail Spanberger (D) to the state’s adult-use cannabis sales bill, 13 News Now reports. Instead of approving the governor’s amendments, lawmakers decided to send the bill back to her desk without making any changes, potentially risking a veto. Lawmakers passed the proposal in March. However, last week, on the last day possible to take action on the bill, Gov. Spanberger, instead of signing or vetoing the proposal, opted to attach several amendments to the bill and send it back to lawmakers. The . . .

Texas retailers carrying hemp flower and pre-rolls can continue selling the products until at least April 28 following delays to the next trial in a lawsuit challenging the state’s ban on smokable hemp products, Texas Public Radio reports. Filed early this month by the Texas Hemp Business Council, Hemp Industry & Farmers of America, and multiple hemp industry operators including retailers, manufacturers, and farmers, the lawsuit argues that the state’s ban on smokable hemp products is unconstitutional because it was established by the Department of State Health Services (DSHS), an . . .

Federal health officials are taking steps that they say will help with “accelerating” therapeutic access to psychedelics for patients dealing with serious mental health conditions. Following President Donald Trump’s signing an executive order aimed at expanding and expediting research on the medical benefits of psychedelics, the Food and Drug Administration (FDA) on Friday announced a series of regulatory actions to support the development of psychedelics as approved medications. “Under President Trump’s leadership, we are accelerating the research, approval, and responsible access to . . .

Statistics Canada released February retail sales for the country, with cannabis sales decreasing from the January levels, down 7.9% to C$440.5 million from the prior month. The sequential decrease was up 2.0% on a per-day basis more due to the fewer days than in the prior month. January, originally reported at C$466.1 million, was revised higher to [ . . . ]

The Trump administration has reportedly reclassified certain types of cannabis at the federal level. Acting Attorney General Todd Blanche announced on social media that the Department of Justice (DOJ) is “rescheduling FDA-approved marijuana and state-licensed marijuana from Schedule I to Schedule III.” RELATED: Anti-cannabis groups sue to block Medicare CBD program Blanche said the Department of Justice was “delivering on President Trump’s promise” to expand Americans’ access to medical treatment options. Under the decisive leadership of @POTUS, this Department of Justice is delivering on . . .

A key congressional committee issued a directive this week for federal agencies to study the “adequacy” of state marijuana laws and to assess methods for “preventing diversion of state legal cannabis product into jurisdictions that do not permit the use of cannabis.” The House Appropriations Committee on Wednesday approved spending legislation and related reports, one of which contains the marijuana provisions. The draft report attached to the Fiscal Year 2027 Financial Services and General Government (FSGG) bill says the panel “recognizes that over 20 States and territories now permit the . . .

Cannabis legalization is fueling a wave of new products-but not the research to back them up, according to a recent study. A paper published in the International Journal of Industrial Organization found that while legalization seems to increase innovation in the realm of commercial cannabis products, it had no impact on medical studies. RELATED: Do cannabis users pay more for insurance? What to know By comparing state-level data on cannabis-related patent applications and clinical trials with policy changes in those states, the researchers, who were from UMass Amherst, saw that cannabis . . .

THE BIG IDEA Hi all, Big news today. Let’s get to it. Alex Send tips, press releases, concerns, feedback and criticism to hello@weedweek.com. Sensitive material to share? Contact Alex on Signal. FROM WEEDWEEK: Trump reschedules MED, with mixed signals on 280E President Donald Trump’s threw a surprise into today’s hotly anticipated cannabis reform announcement by rescheduling state licensed MED, while deferring a decision on rescheduling REC to a DEA process later this year. Which MSO stands to benefit? Also in WeedWeek: Newsbrief: Colorado bill takes aim at lab fraud QUICK HITS Federal: Trump . . .

President Donald Trump’s threw a surprise into today’s hotly anticipated cannabis reform announcement by rescheduling state licensed MED, while deferring a decision on rescheduling REC to a DEA process later this year. Since the Nixon administration, marijuana’s schedule I status has meant the federal government considers it a dangerous substance with no medical value. Today’s announcement moving MED to the much less restrictive schedule III, acknowledges that cannabis has medical value. However, the order, if it holds, could create significantly different financial outcomes for companies, . . .

Americans for Safe Access Statement Regarding DEA and Department of Justice’s Actions to Reschedule Cannabis (Marijuana) for Medical Access “This is a big day for medical cannabis patients. Our federal government recognizes our medicine as legitimate, which means we are not only entitled to tax-free access but to federal protections. For millions of Americans who rely on medical cannabis, this is more than a policy shift – it is validation. It affirms patients’ lived experience and represents an important step in the right direction.

President Donald Trump is urging congressional lawmakers to take action to amend a law that threatens to federally recriminalize hemp-derived full-spectrum CBD products in November. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” the president said in a Truth Social post on Thursday, the same day his administration announced it is moving forward to reschedule marijuana. “We must . . .

Federal officials said they plan to issue new tax guidance for the marijuana industry following a move by the Trump administration to reclassify cannabis that was announced on Thursday. Under an order from Acting Attorney General Todd Blanche, marijuana regulated by a state medical cannabis license will immediately move to Schedule III. Marijuana products such as those in state-legal recreational markets remain in Schedule I for now, however, subject to a hearing process this summer to consider broader rescheduling of cannabis. The U.S. Department of the Treasury and Internal Revenue Service . . .

The NJ Cannabis Regulatory Commission (NJ-CRC) issued more than $25,000 in fines to different cannabis companies for a range of infractions. Unfortunately, none of them went to large Mult-State Operators (MSOs). Hashery Dispensary Fined 20 Grand Chief Counsel Dave Tuason explained that Hashery dispensary used an unapproved RV for advertisements and displayed cannabis paraphernalia openly. [ . . . ] Source: NJ-CRC Issues $25,000 Plus in Fines from Heady NJ

President Donald Trump highlighted the medical benefits of marijuana on Thursday, hours after the Department of Justice announced it is moving ahead with a cannabis rescheduling proposal. “A lot of people are suffering from big problems, which this seems to be the best answer,” the president said in the Oval Office. “They’re very happy about it. So the rescheduling is starting, and that’s a big thing, rescheduling. They kept saying, ‘what about the rescheduling.'” Trump noted that his administration’s actions on cannabis rescheduling came after his friend Howard Kessler told him about how he . . .

Acting US Attorney General Todd Blanche announced that cannabis legalization progress has been made toward moving medical marijuana from a Schedule I to a Schedule III drug. According to a Department of Justice release (DOJ) under President Donald Trump (R), they are “immediately placing both FDA-approved products containing marijuana and marijuana products regulated by a [ . . . ] Source: Acting US Attorney General Moves Medical Marijuana Along Schedule III Process from Heady NJ

Acting U.S. Attorney General Todd Blanche signed an order Thursday to reclassify state-licensed medical cannabis as a less dangerous substance. The order intends to shift the designation of licensed medical cannabis from Schedule I –the most restrictive category of drug classification for substances that have no medical value and potential for abuse including heroin, to the less restrictive Schedule III for substances, or chemicals, defined as drugs with a moderate, to-low potential for physical and psychological dependence alongside Tylenol with Codeine, ketamine, anabolic steroids, and . . .

The NJ Cannabis Regulatory Commission (NJ-CRC) elected Harris Laufer as the new Chair and Jackie Ferraro as Vice Chair. The March 2026 NJ-CRC meeting was the last meeting of former Chair Dianna Houenou and the first of Ferraro. New NJ-CRC Chair and Vice Chair Elected At the beginning of the meeting, then Vice Chair Krista [ . . . ] Source: NJ-CRC Elects Former Scutari Aide Harris Laufer as Chair from Heady NJ

The Trump administration’s announcement that it is moving ahead with the federal reclassification of marijuana on Thursday is generating headlines and drawing reactions from across the political spectrum. Lawmakers, advocacy groups and celebrities are weighing in-with many saying the move is long overdue, others arguing it doesn’t go far enough and some expressing concerns about what they fear will be negative consequences of the cannabis reform. Here’s what people are saying about federal marijuana rescheduling: Lawmakers And Elected Officials Sen. Tom Cotton (R-AR) Marijuana today is much . . .

A Tennessee lawmaker is calling on the governor and legislative leaders to convene a special session focused on legalizing medical marijuana access for patients. “For years, Tennesseans have been told to wait,” Rep. Jason Powell (D) said in a press release. “We created a commission. We studied the issue. We have heard from patients, doctors and families across this state. At some point, we have to be willing to act.” The legislature is set to adjourn for the year this week, but Powell wants Gov. Bill Lee (R) to call lawmakers back to the Capitol to create a state medical cannabis framework as . . .

U.S. joins much of the world in acknowledging medical marijuana The U.S. has joined much of the world in acknowledging medical marijuana. Let international trading begin! Effective April 22, 2026, the Attorney General “hereby order[s] that FDA-approved drug products containing marijuana, as well marijuana in any form covered by a state medical marijuana license, be placed in schedule III of the CSA.” Based on this order, the United States acknowledges medical marijuana and has a fully functioning medical marijuana program (via state licensees). The final order applies to: (a) marijuana as . . .

“Today’s order marks a historical reversal in federal cannabis policy. It validates the experiences of tens of millions of Americans, as well as those of tens of thousands of physicians, who have long recognized that cannabis possesses legitimate medical utility, as well as the legitimacy of the longstanding medical cannabis access programs available in the majority of US states.” The post Justice Department Moves to Federally Reschedule State-Approved Medical Cannabis Products appeared first on NORML.